Alexander J Denner sold $21M of IRWD
director at IRONWOOD PHARMACEUTICALS INC. 6,730,800 shares at an average of $3.05, traded Mar 17, 2026, filed Mar 17, 2026.
Score components
- +15RoleDirector
- +25Trade size$20.5M at market
- +10Share of holdings soldSold 42% of holdings
- 0ClusterNo other insider selling within 14 days
What happened after comparable sells
Same side and tier, against the S&P 500, at 1, 3 and 6 months. Shown to Pro users; the whole table is on the backtest page.
This signal so far: 1m +33.2%, 3m +12.6%, 6m +24.9%.
Price around the trade, and since
From a quarter before the trade to today. The arrow is the trade, the circle the day the filing reached EDGAR, which is the first day anyone outside could act; the dotted line is the S&P 500 rebased to that day's close.
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value; the dashed line is the close on the filing day, the dotted line SPY rebased to it.Charts by TradingView Lightweight Charts™
Rows in this filing
Every transaction in Form 4 0001193125-26-111581, as filed. Open on EDGAR
| Date | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|
| Mar 13, 2026 | AGrant or award Class A Common Stock | +4,451 | $0.00 | $0 | 256,309 | Mar 17, 2026 |
| Mar 17, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote | -6,725,000 | $3.05 | $21M | 9,194,435 | Mar 17, 2026 |
| Mar 17, 2026 | SOpen-market sale Class A Common Stockindirect: See footnote | -5,800 | $3.31 | $19k | 9,188,635 | Mar 17, 2026 |
Related signals
Other insiders at IRONWOOD PHARMACEUTICALS INC and this insider’s other filings.
| Score | Company | Insider | Value | Holdings | Filed |
|---|---|---|---|---|---|
| 24Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver PFO & PAO | $578k 127,890 shares | -29% | |
| 4Weak | IRONWOOD PHARMACEUTICALS INC | Julie McHugh director | $80k 21,571 shares | -8% | |
| 39Weak | IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $80k 21,526 shares | -9% | |
| 39Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver Principal Accounting Officer | $90k 24,173 shares | -9% | |
| 66Notable | IRONWOOD PHARMACEUTICALS INC | Thomas A MCCOURT Chief Executive Officer | $740k 198,283 shares | -12% | |
| 40Moderate | IRONWOOD PHARMACEUTICALS INC | Michael Shetzline SVP, CMO, Head-Res&Drug | $122k 32,582 shares | -6% | |
| 41Moderate | IRONWOOD PHARMACEUTICALS INC | Minardo John Chief Legal Officer | $136k 36,492 shares | -9% | |
| 51Moderate | IRONWOOD PHARMACEUTICALS INC | Gregory S. Martini Chief Financial Officer | $82k 21,944 shares | -12% | |
| 11Weak | IRONWOOD PHARMACEUTICALS INC | Ronald Silver Principal Accounting Officer | $163k 35,416 shares | -11% | |
| 15Weak | IRWDsell IRONWOOD PHARMACEUTICALS INC | Tammi L Gaskins Chief Commercial Officer | $20k 6,016 shares | -2% |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.